GlassScriptPhysician profile
Michael J Matteucci
NPI 1598817157
$3,480.50
in general payments reported to CMS, 2019-2025
35 companies · $759 in 2025
The $759 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $241 · 2021: $184 · 2022: $601 · 2023: $509 · 2024: $910 · 2025: $759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,980 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,979.71 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $638.16 | 2019-2025 | Erleada, Akeega, Balversa |
| Dendreon Pharmaceuticals LLC | $487.70 | 2020-2025 | Provenge |
| Astellas Pharma US INC | $351.20 | 2019-2025 | Xtandi |
| Abbvie INC. | $296.47 | 2019-2025 | |
| Pfizer INC. | $178.39 | 2019-2025 | |
| Urogen Pharma, INC. | $126.50 | 2023-2025 | Jelmyto |
| Medtronic, INC. | $118.08 | 2021-2024 | Aps |
| Sumitomo Pharma America, INC. | $112.76 | 2023-2025 | Gemtesa |
| Procept Biorobotics Corporation | $95.29 | 2022-2025 | Aquabeam System |
| Boston Scientific Corporation | $89.65 | 2019-2025 | Rezum Generator, Axonics |
| Axonics, INC. | $84.83 | 2023-2024 | Axonics, Bulkamid |
| 180 Medical, INC. | $83.25 | 2021-2025 | |
| Teleflex LLC | $74.67 | 2021-2025 | Barrigel, Urolift |
| Ambu INC. | $70.02 | 2024 | |
| Allergan, INC. | $64.36 | 2020-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valencia Technologies Corporation | $60.14 | 2022 | |
| Neotract INC. | $59.89 | 2019-2020 | |
| Urovant Sciences INC | $51.84 | 2022 | |
| Olympus America INC. | $50.07 | 2022-2024 | Itind System |
| Immunitybio, INC. | $44.78 | 2025 | |
| Endo USA, INC. | $39.52 | 2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $36.76 | 2022-2024 | Aveed, Xiaflex |
| Janssen Scientific Affairs, LLC | $31.31 | 2019 | |
| Telix Pharmaceuticals | $30.55 | 2025 | Illuccix |
| Progenics Pharmaceuticals, INC. | $27.13 | 2022 | |
| Tolmar, INC. | $21.62 | 2025 | Eligard, Jatenzo |
| Tolmar Pharmaceuticals, INC. | $20.50 | 2020 | |
| Travere Therapeutics, INC. | $20.34 | 2019 | |
| Ge Healthcare | $19.01 | 2022 | |
| Calyxo, INC. | $18.93 | 2025 | Cvac Aspiration System |
| Laborie Medical Technologies Corp. | $18.17 | 2023 | |
| Myovant Sciences INC. | $17.92 | 2021 | |
| Glaxosmithkline, LLC. | $16.67 | 2020 | |
| Civco Medical Instruments | $12.13 | 2025 | |
| Rochester Medical Corporation | $11.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Matteucci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.